Advisory Services Network’s Karyopharm Therapeutics KPTI Stock Holding History

Advisory Services Network’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$67	Buy	+12	New	+$91	﹤0.01%	4733
2025 Q4	–	Sell	-12	Closed	-$78	–	3167
2025 Q3	$78	Buy	+12	New	+$65	﹤0.01%	4407
2024 Q1	–	Sell	-33	Closed	-$433	–	2654
2023 Q4	$433	Buy	+33	New	+$445	﹤0.01%	3639
2023 Q2	–	Sell	-40	Closed	-$2.33K	–	2634
2023 Q1	$2.33K	Hold	40	–	–	﹤0.01%	3397
2022 Q4	$2.04K	Buy	+40	New	+$2.77K	﹤0.01%	3425
2021 Q3	–	Sell	-60	Closed	-$9K	–	2403
2021 Q2	$9K	Buy	+60	New	+$8.71K	﹤0.01%	2852
2021 Q1	–	Sell	-60	Closed	-$14K	–	2213
2020 Q4	$14K	Hold	60	–	–	﹤0.01%	2279
2020 Q3	$13K	Buy	+60	New	+$14.7K	﹤0.01%	2283

Other funds holding KPTI

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Advisory Services Network's KPTI Position: Q1 2026 in Review

Advisory Services Network opened a new position in Karyopharm Therapeutics (KPTI) in Q1 2026: 12 shares worth $67. The stake represents ﹤0.01% of the portfolio and ranks #4733 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in KPTI as recently as Q3 2025.

Advisory Services Network first reported a position in KPTI in Q3 2020 and has held it in 8 quarters since. The position peaked at $14K in Q4 2020. 77 funds tracked by Wall St. Rank hold KPTI as of Q1 2026.

Advisory Services Network held 12 shares of Karyopharm Therapeutics worth $67 as of Q1 2026.
Karyopharm Therapeutics was a new Advisory Services Network position in Q1 2026.
Karyopharm Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4733 holding.
Advisory Services Network first reported a position in Karyopharm Therapeutics in Q3 2020 and has held it in 8 quarters since.
Advisory Services Network's Karyopharm Therapeutics position peaked at $14K in Q4 2020.
77 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.